Results: 1-8 |
Results: 8

Authors: Chen, JF Xu, K Petzer, JP Staal, R Xu, YH Beilstein, M Sonsalla, PK Castagnoli, K Castagnoli, N Schwarzschild, MA
Citation: Jf. Chen et al., Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in amodel of Parkinson's disease, J NEUROSC, 21(10), 2001, pp. NIL_1-NIL_6

Authors: Steyn, SJ Castagnoli, K Steyn, S Castagnoli, N
Citation: Sj. Steyn et al., Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels, EXP NEUROL, 168(2), 2001, pp. 434-436

Authors: Liu, X Castagnoli, K Van der Schyf, CJ Castagnoli, N
Citation: X. Liu et al., Studies on the in vivo biotransformation of the tobacco alkaloid beta-nicotyrine, CHEM RES T, 13(5), 2000, pp. 336-341

Authors: Liu, X Zang, LY Van der Schyf, CJ Igarashi, K Castagnoli, K Castagnoli, N
Citation: X. Liu et al., Studies on the pyrrolinone metabolites derived from the tobacco alkaloid 1-methyl-2-(3-pyridinyl)pyrrole (beta-nicotyrine), CHEM RES T, 12(6), 1999, pp. 508-512

Authors: Kirby, ML Castagnoli, K Bloomquist, JR
Citation: Ml. Kirby et al., In vivo effects of deltamethrin on dopamine neurochemistry and the role ofaugmented neurotransmitter release, PEST BIOCH, 65(3), 1999, pp. 160-168

Authors: Inoue, H Castagnoli, K Van der Schyf, C Mabic, S Igarashi, K Castagnoli, N
Citation: H. Inoue et al., Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives, J PHARM EXP, 291(2), 1999, pp. 856-864

Authors: Mabic, S Castagnoli, K Castagnoli, N
Citation: S. Mabic et al., Oxidative metabolic bioactivation of xenobiotics, HANDBOOK OF DRUG METABOLISM, 1999, pp. 49-79

Authors: Zhao, ZY Mabic, S Kuttab, S Franot, C Castagnoli, K Castagnoli, N
Citation: Zy. Zhao et al., Rat liver microsomal enzyme catalyzed oxidation of 1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridine, BIO MED CH, 6(12), 1998, pp. 2531-2539
Risultati: 1-8 |